Morning All!
Innovaderma ( Innovaderma (LON:IDP) ) – 190.6p – £27.4m – PER 12.0
Results For The 6 Months To End December 2017 – Revenue up 31%, Loss Before Tax of £0.03m due to investment in people and product launches. Expects Revenue and Profits to grow considerably in H2 and confident of meeting FY market expectations.
Remains on my Watchlist at 180p, always tempted to buy a few of these although it does seem quite speculative – Stockopedia agrees and classes it as “Highly Speculative”.
Jarvis Securities ( Jarvis Securities (LON:JIM) ) – 537p – £58.8m – PER 16.9
Results For The 12 Months To End December 2017 – This is impressive - A 22% increase in PBT and EPS and a 34% increase in the Dividend. However, the outlook is cautious in that MIFID II will require higher costs.
There’s a lot to like here and it’s nice to see caution where it’s due. Tempted as I am for now I am just going to remain Neutral.
Trifast ( Trifast (LON:TRI) ) – 246p – £297.9m – PER 18.2
Q3 Trading Update – A bit of waffle but it seems to be in-line for FY expectations.
Still quite like this but I don’t see value here at all for this slow grower. The yield (sub 2%) doesn’t even make it more attractive.
Sanderson ( Sanderson (LON:SND) ) – 86.9p – £51.6m – PER 13.7
AGM Statement – Board cautious but has a good level of confidence it will make continued progress.
Based on the fundamentals alone this looks like a decent company but I just can’t get excited about it.
Laura Ashley Holdings ( Laura Ashley Holdings (LON:ALY) ) – 6.1p – £44.4m – PER 5.95
Interim Results For The 6 Months To End December 2017 – Not very promising at all. Revenue of £134.7m vs £146.0m last time, PBT of £4.3m (£7.8m last time) and the Interim Dividend is passed. GBP weakness blamed and FY PBT expected to below market expectations.
Looks like Laura Ashley is in terminal decline here -…
